Cystic Fibrosis: all 1,605 studies
Page 10 of 17. Open to participants first (196), then studies with results posted, then the rest; newest registration first within each.
- Project 2 Airway Potential Hydrogen (pH) in AsthmaCompletedNCT03617718Phase 1/2
- Study for Evaluating the Real Use of Inhaled Aztreonam Lysine in Patients With Cystic FibrosisStatus unknownNCT03607396
- Airway Clearance Therapy on Hyperpolarized 129Xenon and MRICompletedNCT03593434
- Study Assessing PTI-428 Safety, Tolerability, Pharmacokinetics and Effect in Subjects With Cystic FibrosisCompletedNCT03591094Phase 2
- Pharmacokinetics of GLPG3067 in Male Subjects With Cystic Fibrosis.CompletedNCT03589313Phase 1
- Implementation of a Non-invasive Version of the Imaging β-adrenergic-dependent Sweat Secretion TestStatus unknownNCT03584841Not applicable
- Determinants of Early Cystic Fibrosis Lung DiseaseCompletedNCT03579173
- Neurodevelopmental Assessment of Infants With Cystic FibrosisCompletedNCT03577756
- Markers of Pulmonary Dysbiosis Associated With Exacerbation in Patients Followed for Cystic FibrosisStatus unknownNCT03569904
- Lum-Iva-biota: Exploring the Respiratory Mycobiota and Microbiota Profile in French CF Patients Taking Lumacaftor-IvacaftorStatus unknownNCT03565692
- Telehealth Cognitive Behavioral Stress Management for Adults With Cystic FibrosisCompletedNCT03560726Not applicable
- A Study Looking at the Safety, Tolerability and Efficacy of the Combination of the Study Drugs GLPG2451 and GLPG2222 With or Without GLPG2737 in Patients With Cystic Fibrosis.CompletedNCT03540524Phase 1
- A Study to Compare the Pharmacokinetics of Different Oral Formulations of FDL169 in Healthy SubjectsCompletedNCT03527095Phase 1
- Evaluation of Sit-to-stand Test in Patients With Cystic Fibrosis and Matched Controls.CompletedNCT03524859
- CF BronchodilationActive, not recruitingNCT03522831Not applicable
- The Effectiveness of the Jamboxx Respiratory Therapy Device: Study 2WithdrawnNCT03522480Not applicable
- Effects of an Individualized Exercise Program on Health-related and Skill/Performance-related fitness in CF.CompletedNCT03518697Not applicable
- A Drug-Drug Interaction Study of FDL169 and FDL176 in Healthy SubjectsCompletedNCT03516331Phase 1
- Risk Factors of Meconium Obstruction and Respiratory Distress Syndrome in Preterm InfantsCompletedNCT03513640
- Observational Study of Glucose Tolerance Abnormalities in Patient With Cystic Fibrosis Homozygous for Phe 508 Del CFTR Treated by Lumacaftor-IvacaftorCompletedNCT03512119
- Extracorporeal Photopheresis in Lung Transplant Rejection for Cystic Fibrosis (CF) PatientsStatus unknownNCT03500575Not applicable
- Safety, Tolerability, and Pharmacokinetics of PTI-808, PTI-801, and PTI-428 Combination Therapy in Subjects With Cystic FibrosisCompletedNCT03500263Phase 1/2
- 19F MRI of Ventilation in Subjects With Cystic Fibrosis Undergoing Treatment for Pulmonary ExacerbationTerminatedNCT03497117Early Phase 1
- Bacteriological Link Between Upper and Lower Airways in Cystic Fibrosis and Primary Ciliary DyskinesiaCompletedNCT03494894
- Study of Circulating Blood Cell Monocytes as Predictive Biomarker of Bone Cystic Fibrosis Disease. Impact of CFTR Correctors.CompletedNCT03492567Not applicable
- 19F MRI to Evaluate Regional Ventilation in Healthy Subjects and Subjects With Cystic FibrosisCompletedNCT03489590Early Phase 1
- A Study Evaluating Safety and Pharmacokinetics of VX-440 in Combination With Tezacaftor/Ivacaftor in Healthy Adult SubjectsCompletedNCT03486236Phase 1
- DPI-Tobra-Kind Cyclops® in Children With Cystic FibrosisStatus unknownNCT03485456Phase 1/2
- Comparison of 129Xe MRI With 19F MRI in CF Lung DiseaseCompletedNCT03482960Early Phase 1
- Real-life Follow-up of Cystic Fibrosis Patients Treated With Ivacaftor+Lumacaftor (Orkambi*)CompletedNCT03475381
- GLPG2737 on Top of Orkambi in Subjects With Cystic FibrosisCompletedNCT03474042Phase 2
- Ready to Use Therapeutic Food (RUTF) to Promote Growth in Cystic FibrosisCompletedNCT03462056Phase 1/2
- Pharmacokinetics of GLPG2737 in Male Subjects With Cystic FibrosisCompletedNCT03450720Phase 1
- Airway Clearance System (K031876) Phase IV Device EfficacyCompletedNCT03437811
- Effect of Losartan in Cystic Fibrosis (CF)-NIH Grant #133240CompletedNCT03435939Early Phase 1
- Outcomes in CF Patients Accessing Their Registry Health RecordsCompletedNCT03434886Not applicable
- Prevalence and Impact of Depression and Anxiety in Cystic FibrosisCompletedNCT03424486
- An Phase 1 Study to Evaluate the Pharmacokinetic (PK) Profile of FDL169 New Formulations in Healthy SubjectsCompletedNCT03424252Phase 1
- Effects of a Comprehensive Patient-centered Health Service in Cystic Fibrosis (VEMSE-CF)CompletedNCT03423576Not applicable
- Modified Release Posaconazole in Patients With Cystic FibrosisStatus unknownNCT03421366
- The Effect of Proprioceptive Neuromuscular Facilitation (PNF) Technique for Children With Chronic Pulmonary Diseases.CompletedNCT03420209Not applicable
- Effects of Inhaled Bicarbonate on Airway pH in Cystic FibrosisCompletedNCT03391414Phase 1
- Canadian Observation Trial in CF Patients Undergoing Treatment With IvacaftorCompletedNCT03390985
- Fidgety Movements in Cystic FibrosisCompletedNCT03381157
- Breath Analysis in Children by New Point-of-care InstrumentsCompletedNCT03377686
- Effects of Inspiratory Muscle Training on Postural Stability, Balance, Pulmonary Function and Functional Capacity in Children With Cystic FibrosisCompletedNCT03375684Not applicable
- A New Optical Sweat Test Method Based on a Citric Acid-derived Multi-halide SensorTerminatedNCT03367494Not applicable
- Non-respiratory Comorbidities Observed in Pulmonary French Transplant Patients With Cystic FibrosisCompletedNCT03357913
- MR Imaging of Lung in the Follow-up Assessment of Cystic FibrosisTerminatedNCT03357562Not applicable
- CHaractErizing CFTR Modulated Changes in Sweat Chloride and Their Association With Clinical OutcomesActive, not recruitingNCT03350828
- Combined Dry Powder Tobramycin and Nebulized Colistin Inhalation in CF PatientsCompletedNCT03341741Phase 3
- Longitudinal Assessment of Exercise Capacity and Vascular Function in Patients With CFCompletedNCT03338595
- Longitudinal Analysis of Respiratory and Intestinal Microbiome in Cystic FibrosisStatus unknownNCT03335202
- Exploratory Study on Link Between Dynamic Hyperinflation and Lung Clearance Index in Cystic FibrosisCompletedNCT03323983
- Multiple Breath Washout, a Clinimetric DatasetStatus unknownNCT03320382
- Evaluation of Food Insecurity in Adults and Children With Cystic FibrosisCompletedNCT03318328
- Examination of the Lipid Metabolism of the Liver After Choline Substitution in Cystic FibrosisCompletedNCT03312140Not applicable
- Epidemiology and Clinical Characteristics of Non-Tuberculous Mycobacteria Infections in Cystic Fibrosis Patients.TerminatedNCT03312075
- A Study of the Safety and Tolerability of Inhaled SNSP113 in Healthy Subjects and Subjects With Stable Cystic FibrosisTerminatedNCT03309358Phase 1
- MUCOviscidose EXacerbation Outils Connectés Education ThérapeutiqueTerminatedNCT03304028Not applicable
- SAFETIM-needs : Exploring Adolescent's and Parent's Needs During Transition in French CF CentersCompletedNCT03298685
- Clinical Trial to Assess Influence of MyCyFAPP Use on GI Related QOL in Children With Cystic FibrosisStatus unknownNCT03292718Not applicable
- Pregnancies and Cystic FibrosisStatus unknownNCT03290144
- The Effects of Discontinuation of Vitamin K Antagonists on the Rate of Elastin DegradationStatus unknownNCT03285100
- MRI in Cystic Fibrosis and Primary Ciliary DyskinesiaStatus unknownNCT03279965
- Tezacaftor/Ivacaftor Combination Therapy Expanded Access Program for Patients 12 Years of Age and Older With Cystic FibrosisApproved for marketingNCT03278314
- Program Of Exercises During The Hospitalization Of Children And Adolescents With Cystic FibrosisStatus unknownNCT03273959Not applicable
- HPV Vaccination in Women With Cystic FibrosisCompletedNCT03265743
- Utility of Point Shear-wave Elastography to Assess for Hepatic & Pancreatic Fibrosis in Pediatric CF PatientsStatus unknownNCT03264950Not applicable
- IPV vs CPT for Airway Clearance During CF ExacerbationWithdrawnNCT03261219Not applicable
- Study Assessing PTI-428 Safety, Tolerability, and Pharmacokinetics in Subjects With Cystic Fibrosis on KALYDECO® as Background TherapyCompletedNCT03258424Phase 1
- High Resolution Micro OCT ImagingActive, not recruitingNCT03256773
- Study Designed to Assess the Safety, Tolerability and PK of PTI-808 in Healthy Volunteers and in Adults With Cystic FibrosisCompletedNCT03251092Phase 1/2
- A CFit Study - Acute ExerciseTerminatedNCT03237767Not applicable
- A CFit Study - BaselineTerminatedNCT03234387
- Interactive Video Game Responses in Cystic FibrosisCompletedNCT03229213
- Simplification of CF-related Diabetes Screening at HomeCompletedNCT03227094Not applicable
- Nutritional Intervention and Glycemic Improvement in Patients With Pre-diabetic Cystic Fibrosis.CompletedNCT03205904Not applicable
- Respiratory Muscle Training in CF PatientsCompletedNCT03190031Not applicable
- A Study to Assess the Safety, Tolerability and PK Profile of FDL176 in Healthy and CF ParticipantsCompletedNCT03173573Phase 1
- Telavancin Pharmacokinetics in Cystic Fibrosis PatientsCompletedNCT03172793Phase 4
- SynRinse Irrigation Pilot (SIP) TrialCompletedNCT03154541Phase 1/2
- Exercise Capacity in Patients With Cystic Fibrosis vs. Non-cystic Fibrosis BronchiectasisStatus unknownNCT03147651
- Efficacy of Nasal Irrigation With Respimer® Netiflow® vs Saline Among Patients With Cystic Fibrosis and Chronic RhinosinusitisStatus unknownNCT03145051Not applicable
- Study Assessing the Safety, Tolerability, Pharmacokinetics, Food Effect, and Drug-Drug Interactions of PTI-801 in Healthy Volunteers, and Safety, Tolerability, and Pharmacokinetics of PTI-801 in Subjects With Cystic FibrosisCompletedNCT03140527Phase 1
- Project UPLIFT to Reduce Anxiety and Depression in CF PatientsCompletedNCT03139266Not applicable
- Use of Personal Fitness Device in Adult (> 21 Years Old) Patients With Cystic FibrosisCompletedNCT03122418Not applicable
- 1STST and Muscle Weakness in CF PatientsCompletedNCT03117764Not applicable
- Do More, B'More, Live FitCompletedNCT03109912Not applicable
- Effects of an Early Rehabilitation Program During Hospitalization in Patients With Cystic FibrosisCompletedNCT03100214Not applicable
- A Study to Evaluate Safety, PK and PD of FDL169 in Cystic Fibrosis SubjectsCompletedNCT03093714Phase 1
- Evaluation of an Airway Clearance SystemCompletedNCT03091062Not applicable
- Airway Alkalinization and Nasal ColonizationCompletedNCT03078088Phase 1
- Prednisone in Cystic Fibrosis Pulmonary ExacerbationsCompletedNCT03070522Phase 3
- Virtual Care in CF (VIRTUAL-CF) StudyStatus unknownNCT03069651Not applicable
- Sit-to-stand Test in Cystic Fibrosis Children and AdolescentsCompletedNCT03069625Not applicable
- Evaluation of Short Antibiotic Combination Courses Followed by Aerosols in Cystic FibrosisTerminatedNCT03066453Phase 3
- Human MesenchymAl Stem Cells Infusion in Patients With Cystic FibrosisWithdrawnNCT03058068Phase 1
- A Safety Study of SPX-101 Inhalation Solution in Subjects With Cystic FibrosisCompletedNCT03056989Phase 1
- A Study to Investigate Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of CHF6333 in Healthy SubjectsCompletedNCT03056326Phase 1